Results-31-03-2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shree Hari Chemicals Export reported FY2025-26 standalone revenue of Rs. 1,845.05 lakh, up 30.7% from Rs. 1,411.96 lakh in FY2024-25. However, profitability declined — standalone PAT fell 20.7% to Rs. 422.22 lakh (from Rs. 532.40 lakh) and PBT dropped 23.9% to Rs. 529.59 lakh (from Rs. 695.50 lakh). Basic EPS stood at Rs. 7.63 vs Rs. 10.79 prior year. Consolidated PAT also declined 19.2% to Rs. 411.81 lakh. Operating cash flow turned positive at Rs. 662.80 lakh from negative Rs. 79.50 lakh. The company raised Rs. 14.75 crore via preferential issues (Nov 2024–Jul 2025) with nil deviation reported. Borrowings increased significantly — non-current borrowings rose from Rs. 3.35 crore to Rs. 7.28 crore. Auditors issued unmodified opinion; no going concern issues flagged.
Strong topline growth of ~31% is positive, but the ~20% decline in net profit and lower EPS may concern investors focused on profitability. The company appears to be investing heavily in capex (Rs. 1,293 lakh in fixed assets) which may be weighing on near-term margins. Cash flow improvement is a positive sign.